Buzz on the Bullboards: Energy, aviation, and cannabis stocks to watch

After a turbulent start to the week, Canada’s main stock index—the S&P/TSX Composite—has staged a notable rebound, offering investors a glimmer of optimism amid geopolitical uncertainty. The index surged 1.68 per cent on Tuesday to close at 30,354, recovering from Friday’s sharp 1.4 per cent drop triggered by renewed U.S.-China tensions over rare earth exports. The rally was fueled by dovish remarks from U.S. Federal Reserve Chair Jerome Powell, which reignited hopes for interest rate cuts, and was further supported by rising prices in the precious metals and energy sectors.

As the TSX regains momentum, three stocks have emerged in the spotlight. Each company has made headlines with strategic moves that could reshape their growth trajectories and offer compelling opportunities for investors.

This article is a journalistic opinion piece which has been written based on independent research. It is intended to inform investors and should not be taken as a recommendation or financial advice.

Tourmaline and Topaz: Realignment and growth

Tourmaline Oil Corp. (TSX:TOU, Forum) has announced a $200 million bought deal secondary offering of Topaz Energy Corp. (TSX:TPZ, Forum) shares, in partnership with Peters & Co. Ltd. and Scotiabank (TSX:BNS, Forum). Tourmaline will sell eight million Topaz shares at $25.10 each, reducing its stake from 21.3 per cent to 16.1 per cent. The underwriters have an option to purchase an additional 15 per cent of the offering to cover over-allotments.

This move is part of Tourmaline’s long-term strategy to reduce its equity position in Topaz, allowing the latter to continue its evolution as an independent royalty and infrastructure company. The proceeds will help fund Tourmaline’s NEBC Montney development project, a two-phase initiative aimed at systematically developing its most profitable inventory. The project is expected to:

• Increase production by 30 per cent to 850,000 boepd by 2031
• Grow cash flow by over 40 per cent
• Boost free cash flow by more than 2.5x, reaching $2.5–$3.0 billion annually

For investors, this could signal Tourmaline’s commitment to capital discipline and long-term value creation, while Topaz gains enhanced trading liquidity and structural independence.

Bombardier’s Global 8000: Speed meets luxury

At the 2025 NBAA Business Aviation Convention and Exhibition in Las Vegas, Bombardier (TSX:BBD, Forum) unveiled a major milestone: its flagship Global 8000 aircraft has achieved a new top speed of Mach 0.95, making it the fastest business jet in history. With a range of 8,000 nautical miles, the aircraft is designed for ultra-long-range travel and features advanced wing technology that allows access to 30 per cent more airports than competitors.

Bombardier also announced that Comlux Aviation will take delivery of the Global 8000 in 2026, expanding its charter fleet. Not only that, Sojitz Corp. of Japan has ordered two aircraft—one Global 6500 and one Global 8000—for its new Share Jet Program (SJP), Japan’s first shared ownership initiative for ultra-long-range jets.

The Global 8000 is expected to play a central role in the SJP, offering bespoke interiors and a quiet cabin environment tailored for productivity and comfort. Bombardier also signed a 10-year service agreement with SNC for two Global 6500 aircraft outfitted with RAPCON-X technology, supporting high-usage military operations under its Smart Services Defense program.

These developments position Bombardier as a leader in both luxury and defense aviation, with strong momentum heading into 2026.

Tilray Medical expands into Panama

Tilray Medical, a division of Tilray Brands (TSX:TLRY, Forum), has announced its expansion into Panama through a joint venture with Top Tech Global Inc., forming Solana Life Group. The partnership has secured a medical cannabis license from Panama’s National Directorate of Pharmacy and Drugs, authorizing cultivation, manufacturing, import, export, and distribution.

This strategic move allows Tilray to leverage its global expertise alongside Top Tech’s local distribution capabilities. The company aims to:

• Enhance patient access to cannabinoid-based therapies
• Support the Panamanian medical community through education and reliable supply chains
• Collaborate with healthcare professionals and advocacy groups to uphold high standards in medical cannabis

Tilray’s expansion into Latin America underscores its commitment to global growth and patient-centric care, reinforcing its position as a leading supplier of medical cannabis in over 20 countries.

Opportunity amid volatility

This week’s TSX rebound reflects investor resilience in the face of geopolitical and economic uncertainty. For those seeking growth opportunities, Tourmaline’s strategic divestment, Bombardier’s aviation breakthroughs, and Tilray’s international expansion offer compelling narratives backed by strong fundamentals and forward-looking strategies.

As always, investors should consider their risk tolerance and conduct thorough due diligence. But with these three TSX stocks making headlines, the Canadian market continues to offer dynamic opportunities for those ready to navigate its evolving landscape.

For previous editions of Buzz on the Bullboards, click here.

Join the discussion: Find out what everybody’s saying about these stock on Stockhouse’s stock forums and message boards.

Stockhouse does not provide investment advice or recommendations. All investment decisions should be made based on your own research and consultation with a registered investment professional. The issuer is solely responsible for the accuracy of the information contained herein. For full disclaimer information, please click here.